FindTrial
Sign In

Analysis of hidden blood loss and its influential factors in myomectomy

Analysis of hidden blood loss and its influential factors in myomectomy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024728
Enrollment
Unknown
Registered
2019-07-25
Start date
2019-07-25
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leiomyoma

Interventions

myomectomy:No

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
28 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) surgical patients definitely diagnosed as uterine leiomyomas by the postoperative pathology. (2)general anesthesia during operation.

Exclusion criteria

Exclusion criteria: (1) history of hematological diseases. (2) history of gastrointestinal hemorrhage. (3) history of cardiovascular and cerebrovascular diseases, like hypertension and thromboembolism. (4) severe abnormal liver and renal function. (5) history of chronic internal medical and immunity diseases, like diabetes and systemic lupus erythematosus. (6) take drugs that probably affect perioperative blood coagulation. (7) the pregnancy and lactation women. (8) complicated with endometriosis or adenomyosis. (9) complicated with cervical lesion. (10) perioperative blood transfusion. (11) coagulation disorders.

Design outcomes

Primary

MeasureTime frame
The average hidden blood loss was 354.39 mL (SD, 177.69mL);—

Countries

China

Contacts

Public ContactXueqiong Zhu

The Second Affiliated Hospital of Wenzhou Medical University

zjwzzxq@163.com+86 13906640759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026